abstract |
The present invention relates to methods for selectively expanding populations of γδ T cells, compositions and admixtures thereof, and methods of using them as therapeutic agents. The non-engineered and engineered enriched γδ T cell populations of the present disclosure can be used to treat a variety of cancers, infectious diseases, and immune conditions. |